344 related articles for article (PubMed ID: 22846379)
21. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
[TBL] [Abstract][Full Text] [Related]
22. Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review.
Bressi B; Cagliari M; Contesini M; Mazzini E; Bergamaschi FAM; Moscato A; Bassi MC; Costi S
Support Care Cancer; 2021 Apr; 29(4):1811-1824. PubMed ID: 33119791
[TBL] [Abstract][Full Text] [Related]
23. Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study.
Sajid S; Dale W; Mustian K; Kotwal A; Heckler C; Porto M; Fung C; Mohile SG
J Geriatr Oncol; 2016 Mar; 7(2):71-80. PubMed ID: 26916611
[TBL] [Abstract][Full Text] [Related]
24. Physical function in men with prostate cancer on androgen deprivation therapy.
Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
[TBL] [Abstract][Full Text] [Related]
25. Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.
Newton RU; Christophersen CT; Fairman CM; Hart NH; Taaffe DR; Broadhurst D; Devine A; Chee R; Tang CI; Spry N; Galvão DA
BMJ Open; 2019 Apr; 9(4):e024872. PubMed ID: 30987986
[TBL] [Abstract][Full Text] [Related]
26. Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
Lee M; Jim HS; Fishman M; Zachariah B; Heysek R; Biagioli M; Jacobsen PB
Psychooncology; 2015 Apr; 24(4):472-7. PubMed ID: 24924331
[TBL] [Abstract][Full Text] [Related]
27. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
[TBL] [Abstract][Full Text] [Related]
29. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
[TBL] [Abstract][Full Text] [Related]
30. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
[TBL] [Abstract][Full Text] [Related]
31. A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer.
O'Neill RF; Haseen F; Murray LJ; O'Sullivan JM; Cantwell MM
J Cancer Surviv; 2015 Sep; 9(3):431-40. PubMed ID: 25916660
[TBL] [Abstract][Full Text] [Related]
32. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
[TBL] [Abstract][Full Text] [Related]
33. Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer.
Cormie P; Zopf EM
Urol Oncol; 2020 Feb; 38(2):62-70. PubMed ID: 30446448
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
Siebert AL; Lapping-Carr L; Morgans AK
Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
[TBL] [Abstract][Full Text] [Related]
35. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
[TBL] [Abstract][Full Text] [Related]
36. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
Gonzalez BD; Jim HS; Booth-Jones M; Small BJ; Sutton SK; Lin HY; Park JY; Spiess PE; Fishman MN; Jacobsen PB
J Clin Oncol; 2015 Jun; 33(18):2021-7. PubMed ID: 25964245
[TBL] [Abstract][Full Text] [Related]
37. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.
Potosky AL; Reeve BB; Clegg LX; Hoffman RM; Stephenson RA; Albertsen PC; Gilliland FD; Stanford JL
J Natl Cancer Inst; 2002 Mar; 94(6):430-7. PubMed ID: 11904315
[TBL] [Abstract][Full Text] [Related]
38. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
[TBL] [Abstract][Full Text] [Related]
39. Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).
Green A; Newton RU; Smith DP; Tuffaha H; Galvão DA; Heathcote P; Patel MI; Christie D; Egger S; Sara SA; Heneka N; Chambers SK; Dunn J
BMJ Open; 2024 Mar; 14(3):e084412. PubMed ID: 38521521
[TBL] [Abstract][Full Text] [Related]
40. The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: a systematic review.
Chipperfield K; Brooker J; Fletcher J; Burney S
Health Psychol; 2014 Nov; 33(11):1288-97. PubMed ID: 24245841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
